Back

Interleukin-1 blockade with Anakinra in ST-segment elevation acute myocardial infarction: Results from the VCUART3 study

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Emerging treatments in acute coronary syndromes Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Antonio Abbate

University of Virginia, Charlottesville (United States of America)

3 More presentations in this session

Presentation thumbnail
State of the Art - Novel therapies for acute myocardial infarction
Professor G. Heusch (Essen, DE)
Slides Video
Presentation thumbnail
Inhibition of platelet aggregation after subcutaneous administration of a single-dose of selatogrel, a novel P2Y12 antagonist, in acute myocardial infarction: a randomised open-label phase 2 study
Professor P. Sinnaeve (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
KAND567, the first selective small molecule CX3CR1 antagonist in clinical development, mediates anti-inflammatory cardioprotective effects in rodent models of atherosclerosis and myocardial infarction
Professor I. Spyridopoulos (Newcastle-Upon-Tyne, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Emerging treatments in acute coronary syndromes

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources